Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension

Naka Shiratori1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan;2 Shinanozaka Clinic, Tokyo, JapanCorrespondence[email protected]

Yusuke Nishio1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan;2 Shinanozaka Clinic, Tokyo, Japan

Ayaka Takeda1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan;2 Shinanozaka Clinic, Tokyo, Japan

Shio Sugimoto1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan;2 Shinanozaka Clinic, Tokyo, Japan

Kenji Takazawa2 Shinanozaka Clinic, Tokyo, Japan

Naomi Otsuka3 Japan Medical Affairs Group, Santen Pharmaceutical Co. Ltd., Osaka, Japan

Naruhiro Ishida3 Japan Medical Affairs Group, Santen Pharmaceutical Co. Ltd., Osaka, Japan

Daisuke Shii3 Japan Medical Affairs Group, Santen Pharmaceutical Co. Ltd., Osaka, Japan

Kiyotaka Hori3 Japan Medical Affairs Group, Santen Pharmaceutical Co. Ltd., Osaka, Japan

Kenji Nakamoto1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan

Articles from other publishers (1)